METHOD OF CROP PLANTS GROWTH REGULATION WITH NATURAL ABSCISIC ACID AND THE COMPOSITION THEREOF

Details for Australian Patent Application No. 2002308933 (hide)

Owner CHENGDU INSTITUTE OF BIOLOGY CHINESE ACADEMY OF SCIENCES SICHUAN LOMON BIO TECHNOLOGY CO., LTD.

Inventors FAN, Xianguo; XIAO, Liang; ZHOU, Jinayn; TAN, Hong

Pub. Number AU-A-2002308933

PCT Number PCT/CN02/00277

PCT Pub. Number WO2002/087329

Priority 01107376.4 25.04.01 CN

Filing date 23 April 2002

Wipo publication date 11 November 2002

International Classifications

A01N 037/06 Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - Unsaturated carboxylic acids or thio-analogues thereof

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 01107376.4 25.04.01 CN

17 April 2003 Application Open to Public Inspection

  Published as AU-A-2002308933

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002308934-PLANT GROWTH REGULATING COMPOSITION FOR STRESSRESISTANCE AND PROMOTING GROWTH

2002308932-METHOD FOR USING PUERARIAE RADIX, PUERARIAE RADIX FLAVONE EXTRACT AND PREPARATION CONTAINING PUERARIN IN THE PREVENTION AND TREATMENT OF NEW INDICATIONS